OpenCharities

Pcd Research

Country
England & Wales
Charity number
1197528
Status
Registered
Registered
Jan. 17, 2022
Legal form
CIO

Address

Address
31A Berrymede Road
LONDON
W4 5JE

Contact

Activities

To advance the health of children and adults with Primary Ciliary Dyskinesia (PCD) by supporting research intoA) Understanding PCDB) Novel therapeutic targets and therapies for PCDC) Advocating for improved standard of care for people with PCD

Objects: The Object Of The CIO Is To Advance The Health Of Children And Adults With Primary Ciliary Dyskinesia (pcd), Involving Inherited Motile Or Non-Motile Ciliary Dysfunction. The CIO Will Carry Out This Object For The Public Benefit By Various Means, Including: • Funding And Supporting Pure Scientific And Applied/translational Research To Understand Inherited Ciliary Dysfunction; • Advocating For An Effective Care Regime And Therapies For Pcd; • Providing Patient Voice To Ensure That Research And Therapeutics Reflect Lived Experiences Of People With Pcd; And • Raising Awareness About Inherited Ciliopathies. Nothing In This Constitution Shall Authorise An Application Of The Property Of The CIO For The Purposes Which Are Not Charitable In Accordance With Section 7 Of The Charities And Trustee Investment (scotland) Act 2005 And Section 2 Of The Charities Act (northern Ireland) 2008

Classification

How
Makes Grants To Individuals, Makes Grants To Organisations, Provides Advocacy/advice/information, Sponsors Or Undertakes Research
What
The Advancement Of Health Or Saving Of Lives
Who
Children/young People, Elderly/old People, People With Disabilities, Other Defined Groups, The General Public/mankind

Areas of operation

Country
Australia, Denmark, France, Germany, Greece, Israel, Italy, Japan, Norway, Portugal, Spain, Switzerland, United States
Region
Throughout England And Wales

Finances

Period end Income Expenditure
Jan. 1, 2025 £238,634 £19,254
Jan. 1, 2024 £40,802 £11,691
Jan. 1, 2023 £153,776 £2,468

Trustees

Name Appointed
Dr Harriet Holme (Chair) Jan. 1, 2022
Dr Gurhan Erturan Jan. 1, 2022
Florence Barkats Nov. 4, 2024
Monica Dawes Nov. 24, 2023
Natalie Gehl Jan. 1, 2022